Zhenjun Yang

3.4k total citations · 1 hit paper
142 papers, 2.8k citations indexed

About

Zhenjun Yang is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Zhenjun Yang has authored 142 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 20 papers in Organic Chemistry and 16 papers in Infectious Diseases. Recurrent topics in Zhenjun Yang's work include Advanced biosensing and bioanalysis techniques (64 papers), RNA Interference and Gene Delivery (61 papers) and DNA and Nucleic Acid Chemistry (36 papers). Zhenjun Yang is often cited by papers focused on Advanced biosensing and bioanalysis techniques (64 papers), RNA Interference and Gene Delivery (61 papers) and DNA and Nucleic Acid Chemistry (36 papers). Zhenjun Yang collaborates with scholars based in China, Thailand and United States. Zhenjun Yang's co-authors include Lihe Zhang, Liangren Zhang, Yun Wu, Xinjing Tang, Changmai Chen, Yufei Pan, Jianjun Hou, Hongwei Jin, Yujia Guo and Zhu Guan and has published in prestigious journals such as Journal of the American Chemical Society, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Zhenjun Yang

140 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications

2020 415 citations Shuaijian Ni, Zhenjian Zhuo et al. ACS Applied Materials & Interfaces profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhenjun Yang China	28	2.0k	359	312	243	209	142	2.8k
Carston R. Wagner United States	36	2.6k 1.3×	251 0.7×	655 2.1×	323 1.3×	587 2.8×	129	3.8k
Kelly M. Stewart Canada	12	1.9k 1.0×	281 0.8×	178 0.6×	173 0.7×	78 0.4×	15	3.4k
Palma Rocchi France	40	3.0k 1.5×	280 0.8×	391 1.3×	330 1.4×	400 1.9×	85	4.5k
Sander I. van Kasteren Netherlands	25	1.5k 0.7×	176 0.5×	913 2.9×	181 0.7×	286 1.4×	71	2.5k
Marc Devocelle Ireland	29	1.3k 0.7×	221 0.6×	448 1.4×	149 0.6×	72 0.3×	83	2.4k
Xiaoqiu Wu China	24	2.3k 1.1×	408 1.1×	139 0.4×	125 0.5×	171 0.8×	67	3.2k
Yuen Yi C. Tam Canada	32	3.5k 1.8×	444 1.2×	97 0.3×	489 2.0×	428 2.0×	44	4.2k
Nicholas M. Riley United States	37	3.2k 1.6×	247 0.7×	532 1.7×	67 0.3×	64 0.3×	74	4.2k
Francisco N. Barrera United States	29	2.2k 1.1×	382 1.1×	129 0.4×	355 1.5×	153 0.7×	80	2.9k

Countries citing papers authored by Zhenjun Yang

Since Specialization

Citations

This map shows the geographic impact of Zhenjun Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenjun Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenjun Yang more than expected).

Fields of papers citing papers by Zhenjun Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenjun Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenjun Yang. The network helps show where Zhenjun Yang may publish in the future.

Co-authorship network of co-authors of Zhenjun Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenjun Yang. A scholar is included among the top collaborators of Zhenjun Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenjun Yang. Zhenjun Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhu, Yuejie, et al.. (2025). A Mannosylated peptidyl lipid CManDA doped into cytidinyl/cationic lipids efficiently delivers siG12Ss to lung cancer in vivo. Journal of Controlled Release. 381. 113624–113624.

Zhao, Xiaoran, Xingxing Liang, Zhongyu Wang, et al.. (2025). NQO1-Activatable Circular Antisense Oligonucleotides for Tumor-Cell-Specific Survivin Gene Silencing and Antitumor Therapy. Journal of Medicinal Chemistry. 68(4). 4466–4476. 2 indexed citations

Pu, Yang, Quanxin Wang, Yufei Pan, et al.. (2025). Cytidinyl/Cationic Lipid Encapsulating Insulin-Like Growth Factor 1 Receptor siRNA for Hepatocellular Carcinoma Therapy. Molecular Pharmaceutics. 22(6). 2939–2951.

Zhu, Yuejie, Qi Zhang, Xudong Sun, et al.. (2024). Aptamer AS411 interacts with the KRAS promoter/hnRNP A1 complex and shows increased potency against drug-resistant lung cancer. RSC Medicinal Chemistry. 15(5). 1515–1526. 2 indexed citations

Yu, Jing, et al.. (2024). Bis-2′-F-cGSASMP isomers encapsulated in cytidinyl/cationic lipids act as potent in situ autologous tumor vaccines. Molecular Therapy. 32(6). 1917–1933. 2 indexed citations

Pan, Yufei, Yuejie Zhu, Yuan Ma, et al.. (2024). Design and synthesis of nucleotidyl lipids and their application in the targeted delivery of siG12D for pancreatic cancer therapy. Biomedicine & Pharmacotherapy. 172. 116239–116239. 1 indexed citations

Pan, Yufei, Jing Guan, Yujing Gao, et al.. (2023). Modified ASO conjugates encapsulated with cytidinyl/cationic lipids exhibit more potent and longer-lasting anti-HCC effects. Molecular Therapy — Nucleic Acids. 32. 807–821. 11 indexed citations

Guan, Jing, Yufei Pan, Yuejie Zhu, et al.. (2022). Activity and Tissue Distribution of Antisense Oligonucleotide CT102 Encapsulated with Cytidinyl/Cationic Lipid against Hepatocellular Carcinoma. Molecular Pharmaceutics. 19(12). 4552–4564. 14 indexed citations

Zhou, Xinyang, Yufei Pan, Lijia Yu, et al.. (2021). Feasibility of cRGD conjugation at 5′-antisense strand of siRNA by phosphodiester linkage extension. Molecular Therapy — Nucleic Acids. 25. 603–612. 11 indexed citations

10.

Zhou, Xinyang, Yufei Pan, Zheng Li, et al.. (2020). siRNA Packaged with Neutral Cytidinyl/Cationic/PEG Lipids for Enhanced Antitumor Efficiency and Safety In Vitro and In Vivo. ACS Applied Bio Materials. 3(9). 6297–6309. 12 indexed citations

11.

Ni, Shuaijian, Zhenjian Zhuo, Yufei Pan, et al.. (2020). Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications. ACS Applied Materials & Interfaces. 13(8). 9500–9519. 415 indexed citations breakdown →

12.

Zhou, Xinyang, Shuhe Wang, Yuejie Zhu, et al.. (2019). Overcoming the delivery barrier of oligonucleotide drugs and enhancing nucleoside drug efficiency: The use of nucleolipids. Medicinal Research Reviews. 40(4). 1178–1199. 14 indexed citations

13.

Zhang, Yanfen, Xinyang Zhou, Jing Sun, et al.. (2019). Construction of a Targeting Nanoparticle of 3′,3″-Bis-Peptide-siRNA Conjugate/Mixed Lipid with Postinserted DSPE-PEG2000-cRGD. Molecular Pharmaceutics. 16(12). 4920–4928. 19 indexed citations

14.

Li, Kunfeng, Yuan Ma, Shaohua Li, et al.. (2018). d-/l-Isothymidine incorporation in the core sequence of aptamer BC15 enhanced its binding affinity to the hnRNP A1 protein. Organic & Biomolecular Chemistry. 16(40). 7488–7497. 7 indexed citations

15.

Yu, Lijia, et al.. (2018). Caged siRNAs with single folic acid modification of antisense RNA for photomodulation of exogenous and endogenous gene expression in cells. Organic & Biomolecular Chemistry. 16(38). 7029–7035. 8 indexed citations

16.

Sun, Jing, Chong Qiu, Wei Wei, et al.. (2017). Delivery Pathway Regulation of 3′,3″-Bis-Peptide-siRNA Conjugate via Nanocarrier Architecture Engineering. Molecular Therapy — Nucleic Acids. 10. 75–90. 14 indexed citations

17.

Ma, Yuan, Shuang Liu, Yusi Wang, et al.. (2017). Isonucleotide incorporation into middle and terminal siRNA duplexes exhibits high gene silencing efficacy and nuclease resistance. Organic & Biomolecular Chemistry. 15(24). 5161–5170. 7 indexed citations

18.

Li, Kunfeng, Hongwei Jin, Zhu Guan, et al.. (2016). Chemical modification improves the stability of the DNA aptamer GBI-10 and its affinity towards tenascin-C. Organic & Biomolecular Chemistry. 15(5). 1174–1182. 26 indexed citations

19.

Qi, Na, et al.. (2011). A novel membrane-permeant cADPR antagonist modified in the pyrophosphate bridge. Chemical Communications. 47(33). 9462–9462. 17 indexed citations

20.

Langhorst, Matthias F., Xianfeng Gu, Lijun Huang, et al.. (2004). Amplification and propagation of pacemaker Ca2+ signals by cyclic ADP-ribose and the type 3 ryanodine receptor in T cells. Journal of Cell Science. 117(10). 2141–2149. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact